$15B speculative biotech and the forum is so quiet?Is there an explanation? Institutional ownership? Not much on the float?One product on the market, no new drugs in the pipeline and such a high market cap; I am surprised this thing is not targeted by short sellers.
<< no new drugs in the pipeline >>I disagree with your statement. ALXN has a solid pipeline which currently contains 16 different trials: 7 trials for new therapies and 9 trials to expand the use of Soliris.
Hi Everyone,IBD overall rank 99 Best in group (pharma)EPS 99 Best in groupIBD has the RS as a 97.Sales, Margin, ROE A second to SCLNHere is where it it a little behind:Acc/ Dist ranked a B+ and 99th in the group Earnings should be good, but what does that mean anymore. If they want a reason to sell they will find it.
What is your comment all about?Why not to go somewhere else to make some noise over there.
noise? what is the point of a forum if nobody makes any comments?it is just an observation of mine: other biotech company forums have much more traffic. i was wondering why?